Preclinical activity of melflufen (J1) in ovarian cancer.
Carlier C, Strese S, Viktorsson K, Velander E, Nygren P, Uustalu M, Juntti T, Lewensohn R, Larsson R, Spira J, De Vlieghere E, Ceelen WP, Gullbo J.
Carlier C, et al.
Oncotarget. 2016 Sep 13;7(37):59322-59335. doi: 10.18632/oncotarget.11163.
Oncotarget. 2016.
PMID: 27528037
Free PMC article.